Category: Disease Prevention & Management

The announcement of the 2026 Laureate Awards by the Endocrine Society marks a significant milestone in the field of hormonal research and clinical practice, highlighting individuals who have demonstrated a lifetime of dedication to the advancement of endocrine science. Among the distinguished honorees, Dr. Martin Reincke stands out for his dual contributions as a high-level…

Lila Dabill, a doctoral candidate at Washington University in St. Louis, has been named the Basic Science winner of the 2026 Rising Star Power Talks, a premier research communication competition held during the Endocrine Society’s annual ENDO conference. Dabill’s research, conducted within the laboratory of Dr. Erica Scheller, investigates the pivotal role of the NADase…

The landscape of metabolic medicine shifted significantly on August 18 as Amylyx Pharmaceuticals, Inc. unveiled the topline results from its pivotal Phase 3 LUCIDITY clinical trial. The study, which evaluated the efficacy and safety of avexitide in patients suffering from post-bariatric hypoglycemia (PBH), met its primary endpoint with high statistical significance. Avexitide, an investigational, first-in-class…

The Endocrine Society’s annual meeting, ENDO 2026, concluded its residency at Chicago’s McCormick Place this past June, marking a pivotal moment in the evolution of endocrine science and clinical practice. As the global medical community sifts through the wealth of data and insights presented during the conference, the event is being recognized not merely for…

The ENDO 2026 annual meeting, held this past June in Chicago, established itself as a landmark event for the global endocrine community, drawing record-breaking attendance during a period of profound transition for the healthcare sector. Despite a climate of economic uncertainty and fluctuating research budgets that have historically hampered long-term scientific inquiry, the field of…

New clinical research presented at the ENDO 2026 annual meeting suggests that glucagon-like peptide-1 (GLP-1) receptor agonists may offer a dual benefit for men, significantly improving both testosterone levels and sperm quality in those suffering from obesity-related hypogonadism. The study, led by Pratibha Natesh, MBBS, MRCP, MRes, an endocrinologist at University Hospitals Coventry and Warwickshire…

The Endocrine Society and Keystone Symposia have announced a landmark partnership to launch a specialized series of scientific meetings aimed at exploring the critical intersections of hormone signaling, oncology, diabetes, and cardiometabolic health. This collaboration represents a significant shift toward interdisciplinary research, seeking to break down traditional silos that have historically separated endocrinology from other…

New research published in the Journal of the Endocrine Society suggests that phthalates—a class of synthetic chemicals ubiquitous in modern consumer goods—may play a significant role in the development of high blood pressure among pregnant women. The study, led by researchers at the Harvard T.H. Chan School of Public Health, highlights a concerning link between…

The medical community is facing a growing challenge as new research reveals that at least one in 12 weight-loss surgery patients develops a severe, recurring low blood sugar condition that necessitates medical intervention. This finding, presented at the prestigious ENDO 2026 conference, highlights a significant and often overlooked complication of bariatric procedures known as post-bariatric…

The annual meeting of the Endocrine Society, known as ENDO 2026, recently served as the backdrop for one of the most high-stakes and fast-paced academic competitions in the field of hormone research: the Rising Star Power Talks. This year, the spotlight shone brightly on Brittany Weisbrot, an internal medicine resident at Loyola University Medical Center…